Aigen Investment Management, LP Amphastar Pharmaceuticals, Inc. Transaction History

Aigen Investment Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$38.65 - $43.48 $199,859 - $224,835	5,171 New	5,171 $206,000
Q2 2023 Aug 14, 2023	BUY	$35.77 - $58.38 $38,238 - $62,408	1,069 Added 13.71%	8,868 $509,000
Q1 2023 May 15, 2023	BUY	$27.99 - $37.92 $218,294 - $295,738	7,799 New	7,799 $292,000
Q3 2021 Nov 12, 2021	SELL	$17.83 - $21.49 $220,913 - $266,261	-12,390 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$17.11 - $20.92 $63,084 - $77,132	-3,687 Reduced 22.93%	12,390 $250,000
Q1 2021 May 11, 2021	SELL	$17.21 - $20.65 $89,405 - $107,276	-5,195 Reduced 24.42%	16,077 $295,000
Q4 2020 Feb 12, 2021	SELL	$17.76 - $21.24 $46,673 - $55,818	-2,628 Reduced 11.0%	21,272 $428,000
Q3 2020 Nov 06, 2020	BUY	$17.99 - $22.22 $429,960 - $531,058	23,900 New	23,900 $448,000
Q2 2020 Aug 10, 2020	SELL	$14.25 - $22.46 $44,659 - $70,389	-3,134 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$12.66 - $20.08 $23,585 - $37,409	1,863 Added 146.58%	3,134 $47,000
Q4 2019 Feb 04, 2020	BUY	$17.07 - $20.64 $21,695 - $26,233	1,271 New	1,271 $25,000

281

36.8M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.59B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.